Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announces the regulatory submission of its Liflow^® 1.0 solution (registered trademark of the Myra project), an oncology platform dedicated to the analysis of diagnostic imaging and cancer follow-up.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and developer of Myrian^®, and Guerbet (FR0000032526 GBT), world leader in medical imaging, are proud to announce that the Myrian^® 2.12 platform has obtained CE certification under MDR, integrating prostate AI developed by Guerbet, the Veolity^® LungCAD AI developed by MeVis Medical Solutions AG and the Icobrain™ AI developed by Icometrix. This market launch is a major step in the two companies' joint development plan and the realization of their growth ambitions.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and the developer of Myrian® (the "Company"), today announced its annual 2023 IFRS consolidated financial results certified at Group level.

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^®, announces its participation at the ECR from February 28 to March 3, in Vienna (Austria).

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^®, is proud to announce that the company has obtained the new CE certification under MDR (European Union Medical Device Regulation 2017/745), authorizing the marketing of the latest version of its Myrian^® solution.